In addition to pushing cuts off until the beginning of 2027, the bill would update the data collection period used to establish the 2027 lab rates from 2019 to 2025.

The trial is being run by the Global Alzheimer's Platform Foundation in partnership with the UK Dementia Research Institute.

The US Food and Drug Administration-approved comprehensive genomic profiling test will be reimbursed at a rate of $2,989.55 per test.

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.

Last week, readers were most interested in a story about the continued lack of clarity around Siemens Healthineers' diagnostics business at JP Morgan.

NEW YORK – Siemens Healthineers has been granted funding from the Gates Foundation to support development of a maternal health screening tool, the firm announced on Friday. The total amount of the ...

Altai Capital said last month it had "serious concerns about the company’s significant share price underperformance." ...

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.

NEW YORK — Several Delta Dental dental health plan administrators said on Thursday that they will begin coverage of OraLiva's oral cancer test.

President and CEO Sam Raha characterized the company's pipeline of new products as "more robust than we've had in five years." ...

Diagnostics is already operating somewhat separately from the firm's other two business units under its new organizational structure, company officials said.